We provide you with 20 years of free, institutional-grade data for HARP stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of HARP. Explore the full financial landscape of HARP stock.
| Reported Date | CIK | Ticker | Type |
|---|
Harpoon Therapeutics, Inc(NASDAQ:HARP) 
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead tri-specific t-cel...
Website: http://www.harpoontx.com
Founded: 2015
Full Time Employees: 77
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about HARP stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.